CircRNA Synthesis Market Size & Growth Forecast 2026–2035, By Segments (Product & Services, Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
CircRNA Synthesis Market size was around USD 206.41 Million in 2025 and is slated to grow at a 15.8% CAGR from 2026 to 2035, reaching USD 894.99 Million by 2035. The industry revenue for 2026 is assessed at USD 235.4 million.
Get more details on this report
Request Free Sample ReportCircRNA Synthesis Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 47.83% share due to strong biotechnology research ecosystem, concentrated RNA innovation activity, and advanced synthesis and analytical infrastructure supporting therapeutic and preclinical applications.
- Asia Pacific grows at 17.7% CAGR driven by expanding biotechnology research capacity, rising RNA-based development activity, and broader adoption of advanced synthesis workflows across institutions.
Segment Momentum
- Reagents & Kits held a 50.13% share in 2025 because they are essential, repeat-use inputs for circRNA synthesis, optimization, and validation, supporting continuous laboratory research and development activities.
- Drug Discovery is expanding rapidly as organizations increase exploratory circRNA research, using flexible synthesis approaches to accelerate candidate evaluation, mechanism studies, and iterative experimental development.
Market Expansion Drivers
- Superior stability and protein expression advantages accelerating circRNA therapeutic development pipelines.
- Rising biotechnology investments supporting commercialization of circRNA-based vaccines and gene therapies.
- Expanding RNA manufacturing platform innovations improving scalable circRNA production efficiency.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Key players in the CircRNA synthesis market include GenScript Biotech Corporation (China), LGC Biosearch Technologies (United Kingdom), Creative Biogene (United States), Applied Biological Materials Inc. (Canada), GeneCopoeia, Inc. (United States), Creative Biolabs (United States), SBS Genetech Co., Ltd. (China), Guangzhou Geneseed Biotech Co., Ltd. (China), Amerigo Scientific (United States), VectorBuilder Inc. (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
The superior intracellular stability of circular RNA is reshaping development priorities in the CircRNA synthesis market because it reduces one of the central limitations associated with linear RNA therapeutics: rapid degradation before sufficient protein production is achieved. That performance advantage makes circRNA more attractive for applications requiring durable expression, prompting developers to expand preclinical and translational programs in vaccines, oncology, protein replacement, and gene modulation. As more drug candidates move from discovery into optimization and early manufacturing planning, demand shifts toward high-purity synthesis services, sequence design capabilities, and process development solutions tailored to circular constructs, directly driving demand for the CircRNA synthesis market.
Rising biotechnology investments supporting commercialization of circRNA-based vaccines and gene therapies
Growing capital flows into RNA-focused biotechnology companies are translating into a more commercial orientation for circRNA platforms, with funding increasingly directed toward candidate advancement, manufacturing readiness, and regulatory preparation rather than exploratory research alone. In the CircRNA synthesis market, this changes purchasing behavior from small-batch experimental synthesis to longer-duration supply relationships that support analytical testing, scale-up, and GMP-aligned production. Investment also lowers the barrier for platform companies to build partnerships with CDMOs and specialist synthesis providers, strengthening market development as circRNA-based vaccines and gene therapies move closer to clinically and commercially relevant volumes.
Expanding RNA manufacturing platform innovations improving scalable circRNA production efficiency
Advances in RNA manufacturing platforms are improving the practical economics of producing circular RNA by addressing bottlenecks in circularization efficiency, impurity control, and batch consistency. For the CircRNA synthesis market, these process improvements make it easier for suppliers to offer reproducible output at scales that better match therapeutic development needs, reducing technical friction for biopharma customers evaluating circRNA programs. As production workflows become more standardized and analytically robust, procurement decisions increasingly favor circRNA synthesis approaches that can transition from research to clinical manufacturing without major process redesign, supporting market expansion through smoother scale-up pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Superior stability and protein expression advantages accelerating circRNA therapeutic development pipelines | 2.00% | Moderate | North America, Europe | High | Near Term |
| Rising biotechnology investments supporting commercialization of circRNA-based vaccines and gene therapies | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Expanding RNA manufacturing platform innovations improving scalable circRNA production efficiency | 1.40% | Moderate | Asia Pacific, North America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional share of the CircRNA synthesis market in 2025, accounting for 47.83% share, bolstered by its established biotechnology research base, strong concentration of RNA-focused innovation activity, and broad availability of advanced synthesis and analytical capabilities. The region’s leadership is strengthened by active use of circular RNA platforms across academic institutes, biopharma companies, and specialized service providers, where demand is tied to preclinical research, therapeutic discovery, and workflow optimization. This operating environment helps sustain purchasing activity for synthesis tools and related services because users typically require high reproducibility, technical support, and access to sophisticated laboratory infrastructure.
Asia Pacific is projected to expand at a 17.7% CAGR over the forecast period, with the CircRNA synthesis market gaining momentum as regional research capacity deepens and RNA-based development activity broadens across both public and private institutions. Growth is being propelled by rising participation in advanced life sciences research, increasing buildout of laboratory capabilities, and stronger adoption of modern RNA synthesis workflows in countries investing in biotechnology and translational medicine. As more regional organizations move from exploratory research into structured development programs, demand is accelerating for scalable synthesis solutions and technical expertise that can support more frequent and complex experimental use.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants/Startups i Scale Low Medium High | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision RNA ManufacturingGermany is advancing CircRNA synthesis through high-quality production technologies and strong life sciences research capabilities. Companies are improving synthesis consistency and analytical validation to support pharmaceutical research and therapeutic innovation.
France 🇫🇷
Translational RNA ResearchFrance is integrating CircRNA synthesis into translational biomedical research focused on innovative therapeutic applications. Academic and biotechnology organizations are enhancing synthesis technologies that improve reproducibility and support efficient research workflows.
Italy 🇮🇹
Academic Biotechnology CollaborationItaly is expanding CircRNA synthesis through collaboration between research institutions and biotechnology developers. Italian organizations are strengthening laboratory capabilities and standardized production methods to support experimental RNA-based therapeutic programs.
Japan 🇯🇵
Advanced RNA EngineeringJapan is expanding CircRNA synthesis capabilities through investments in molecular biology and precision biotechnology research. Research institutions are refining synthesis techniques that enhance RNA stability and support diverse therapeutic development initiatives.
South Korea 🇰🇷
Biotech Platform DevelopmentSouth Korea is strengthening the CircRNA synthesis market through collaborative biotechnology research and manufacturing innovation. Companies are building specialized RNA production capabilities to support expanding therapeutic research and strategic development partnerships.
United States 🇺🇸
Therapeutic Research ExpansionThe U.S. CircRNA synthesis market is supported by active biotechnology research focused on next-generation RNA therapeutics. Organizations are investing in scalable synthesis platforms and robust manufacturing workflows to accelerate preclinical and translational development programs.
Segment Leadership and Growth Trends
CircRNA Synthesis Market Share (%), Product & Services, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportReagents & Kits held the leading position in the CircRNA synthesis market in 2025, accounting for a 50.13% share. This segment’s leadership is underpinned by the routine, repeat-use nature of core synthesis inputs across research and development workflows. Laboratories and biotech teams rely on reagents and kits as the operational foundation for circRNA construction, optimization, and validation, which keeps purchasing frequency high and demand closely tied to day-to-day experimental activity. Their share remains strong because these products are directly embedded in internal lab processes rather than being used only at specific project stages.
Services are emerging as the fastest-growing segment in the CircRNA synthesis market as more organizations seek external support for technically demanding synthesis work without building full in-house capabilities. Growth is being driven by the practical need for specialized expertise, workflow efficiency, and access to tailored synthesis support, particularly where development timelines and experimental complexity make outsourcing more attractive than internal execution. Relative to products alone, services gain momentum because they help users overcome capability gaps and accelerate progress in projects that require precision and process consistency.
Application Segment Analysis: Therapeutics Development (Largest Segment) vs Drug Discovery (Fastest-Growing Segment)
By 2025, Therapeutics Development represented the largest application in the CircRNA synthesis market with a 61.9% share. Its leadership reflects the market’s strong alignment with development-stage use cases where circRNA synthesis has direct relevance to building and refining therapeutic candidates. Demand is concentrated here because therapeutics development requires sustained synthesis activity, repeated optimization, and application-specific construct design, creating a deeper and more continuous need for circRNA-related inputs and capabilities than earlier-stage use environments.
Drug Discovery is the fastest-growing application in the CircRNA synthesis market, underpinned by expanding use of circRNA platforms in earlier research workflows where candidate identification and mechanism exploration are becoming more active. This segment is gaining momentum because discovery programs benefit from flexible synthesis approaches that allow rapid testing and iterative experimental design. Compared with therapeutics development, drug discovery is growing faster as organizations broaden exploratory work and evaluate circRNA more actively across a wider range of research questions and potential pipeline opportunities.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product & Services | Reagents & Kits, Instruments, Services | Reagents & Kits | Services |
| Application | Therapeutics Development, Drug Discovery, Others | Therapeutics Development | Drug Discovery |
| End Use | Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others | Pharmaceutical & Biotechnology Companies | Academic & Research Institutes |
Competitive Landscape and Market Positioning
1. GenScript Biotech Corporation (China)
2. LGC Biosearch Technologies (United Kingdom)
3. Creative Biogene (United States)
4. Applied Biological Materials Inc. (Canada)
5. GeneCopoeia Inc. (United States)
6. Creative Biolabs (United States)
7. SBS Genetech Co. Ltd. (China)
8. Guangzhou Geneseed Biotech Co. Ltd. (China)
9. Amerigo Scientific (United States)
10. VectorBuilder Inc. (United States)
The CircRNA synthesis market is advancing through increasing research activity surrounding RNA-based therapeutics and next-generation biotechnology applications. Companies are refining synthesis techniques to improve stability, scalability, and therapeutic efficiency for emerging clinical applications. Collaborative research initiatives and innovation-focused investments are further accelerating technological progress and expanding opportunities within precision medicine development.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Circio Holding ASA | Jun-26 | Circio entered a research collaboration with Tcelltech GmbH to combine its circVec technology with Tcelltech’s non-viral, episomal nanoSMAR DNA vector platform. This partnership aims to overcome limitations in current in vivo T-cell therapies by leveraging the durable, long-term protein expression provided by circular RNA and the high-cargo, non-integrating capacity of the nanoSMAR vector. |
| Circio Holding ASA | May-26 | At the 2026 ASGCT Annual Meeting, Circio presented extensive in vivo data showing that its circVec platform enables 40-fold increased gene expression in cardiac tissue compared to conventional AAV9 vectors. These results demonstrate the platform's potential for substantial AAV dose reduction, directly addressing safety and toxicity challenges inherent in traditional high-dose gene therapy. |
| Orna Therapeutics | Feb-26 | Orna Therapeutics finalized a major licensing agreement with Vertex Pharmaceuticals valued at USD 4.35 billion. This transaction highlights the massive premium being placed on circular RNA platform technologies, specifically for their application in in vivo gene therapy, underscoring the shift toward non-viral, stable expression systems in the RNA therapeutics pipeline. |
| Orna Therapeutics | Oct-25 | Orna Therapeutics and Eli Lilly entered into a definitive acquisition and licensing agreement valued at USD 2.4 billion, focusing on the use of Orna’s circular RNA technology in in vivo CAR-T cell therapy for autoimmune diseases. This deal reinforces the therapeutic versatility of circRNA, moving beyond oncology into high-growth immunological indications. |
| Abogen Biosciences | Aug-25 | Abogen Biosciences received dual Investigational New Drug (IND) approvals in China and the U.S. for its mRNA-based KRAS cancer vaccine (ABO2102). While Abogen continues to advance its mRNA platforms, its earlier development of a proprietary Cis-System for circular RNA production remains a foundational pillar for its ongoing exploration of more stable, longer-acting RNA-based therapeutic candidates. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
CircRNA Synthesis Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
CircRNA Synthesis Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of CircRNA synthesis?
How is the CircRNA synthesis industry size expected to evolve during the forecast period?
How are stability advantages of circRNA accelerating shifts in therapeutic development pipelines?
How is biotechnology investment shaping commercialization pathways in the circRNA synthesis market?
Why are Reagents & Kits the largest segment in the CircRNA synthesis market?
Why is Drug Discovery the fastest-growing application in the CircRNA synthesis market?
Why does North America lead the CircRNA synthesis market?
What is driving Asia Pacific growth in the CircRNA synthesis market?
Which companies dominate the CircRNA synthesis landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization